Switch theme
Sign up to access all valuation multiples
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
1989
275
LTM Revenue $197M
LTM EBITDA -$66.1M
-$55.2M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Amarin Corp has a last 12-month revenue of $197M and a last 12-month EBITDA of -$66.1M.
In the most recent fiscal year, Amarin Corp achieved revenue of $307M and an EBITDA of -$50.7M.
Amarin Corp expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Amarin Corp valuation multiples based on analyst estimates| FY 2022 | FY 2023 | FY 2024 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $369M | $307M | $202M | $197M | XXX |
| Gross Profit | $462M | $242M | $166M | XXX | XXX |
| Gross Margin | 125% | 79% | 82% | XXX | XXX |
| EBITDA | -$101M | -$50.7M | -$64.0M | -$66.1M | XXX |
| EBITDA Margin | -27% | -17% | -32% | -34% | XXX |
| Net Profit | $7.7M | -$106M | -$59.1M | XXX | XXX |
| Net Margin | 2% | -34% | -29% | XXX | XXX |
| Net Debt | n/a | n/a | n/a | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of February 21, 2025, Amarin Corp's stock price is $1.
Amarin Corp has current market cap of $242M, and EV of -$55.2M.
See Amarin Corp trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| -$55.2M | $242M | XXX | XXX | XXX | XXX | $-0.15 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of February 21, 2025, Amarin Corp has market cap of $242M and EV of -$55.2M.
Amarin Corp's trades at -0.3x LTM EV/Revenue multiple, and 0.8x LTM EBITDA.
Analysts estimate Amarin Corp's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Amarin Corp and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | -$55.2M | XXX | XXX | XXX |
| EV/Revenue | -0.3x | XXX | XXX | XXX |
| EV/EBITDA | 0.9x | XXX | XXX | XXX |
| P/E | -4.4x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -1.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAmarin Corp's NTM/LTM revenue growth is -12%
Amarin Corp's revenue per employee for the last fiscal year averaged $1.1M, while opex per employee averaged $0.8M for the same period.
Over next 12 months, Amarin Corp's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Amarin Corp's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Amarin Corp and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -34% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -32% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 26% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -44% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $1.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.8M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 36% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 29% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 7% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 72% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Armata Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Amarin Corp acquired XXX companies to date.
Last acquisition by Amarin Corp was XXXXXXXX, XXXXX XXXXX XXXXXX . Amarin Corp acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Amarin Corp founded? | Amarin Corp was founded in 1989. |
| Where is Amarin Corp headquartered? | Amarin Corp is headquartered in United States of America. |
| How many employees does Amarin Corp have? | As of today, Amarin Corp has 275 employees. |
| Who is the CEO of Amarin Corp? | Amarin Corp's CEO is Mr. Aaron D. Berg. |
| Is Amarin Corp publicy listed? | Yes, Amarin Corp is a public company listed on NAS. |
| What is the stock symbol of Amarin Corp? | Amarin Corp trades under AMRN ticker. |
| When did Amarin Corp go public? | Amarin Corp went public in 1993. |
| Who are competitors of Amarin Corp? | Similar companies to Amarin Corp include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics. |
| What is the current market cap of Amarin Corp? | Amarin Corp's current market cap is $242M |
| What is the current revenue of Amarin Corp? | Amarin Corp's last 12-month revenue is $197M. |
| What is the current EBITDA of Amarin Corp? | Amarin Corp's last 12-month EBITDA is -$66.1M. |
| What is the current EV/Revenue multiple of Amarin Corp? | Current revenue multiple of Amarin Corp is -0.3x. |
| What is the current EV/EBITDA multiple of Amarin Corp? | Current EBITDA multiple of Amarin Corp is 0.8x. |
| What is the current revenue growth of Amarin Corp? | Amarin Corp revenue growth between 2023 and 2024 was -34%. |
| Is Amarin Corp profitable? | Yes, Amarin Corp is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
